drugset / Trial / NCT02292433
A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy
RandomizedCrossoverDouble-blindBasic science
Summary
Study B1621018 will assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Dose Levels of Pf-04937319 in Japanese Subjects with Type 2 Diabetes Mellitus As Monotherapy
Timeline
- Start
- 2015-01
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NERIGLIATIN | Small molecule | 100 mg | — |
| Subject | NERIGLIATIN | Small molecule | 250 mg | — |